Cost Utility Analysis 1) As the director of Centers for Medicare and Medicaid Services (CMS),...

 

Transcribed Image Text:

Cost Utility Analysis ‒‒‒‒‒‒‒‒ 1) As the director of Centers for Medicare and Medicaid Services (CMS), you have to make a decision on coverage of the following oncology agents. Your budget only permits the use $100,000, and you need to maximize the health benefit in quality adjusted life years (QALYS) for these patients. Which medications would you cover? Listed for your reference include the costs, quality of life weight for the health-state, and length of time spent in the health-state. (Hint: First determine what the outcome unit values associated with each drug and cost). Drugs Tumorkinumab Radilumab Multikinumab Suppresumab Costs $45,000 $35,000 $50,000 $40,000 QOL Weight 0.6 0.5 0.8 0.7 Length of Life (Years) 10 5 7 7 Cost Utility Analysis ‒‒‒‒‒‒‒‒ 1) As the director of Centers for Medicare and Medicaid Services (CMS), you have to make a decision on coverage of the following oncology agents. Your budget only permits the use $100,000, and you need to maximize the health benefit in quality adjusted life years (QALYS) for these patients. Which medications would you cover? Listed for your reference include the costs, quality of life weight for the health-state, and length of time spent in the health-state. (Hint: First determine what the outcome unit values associated with each drug and cost). Drugs Tumorkinumab Radilumab Multikinumab Suppresumab Costs $45,000 $35,000 $50,000 $40,000 QOL Weight 0.6 0.5 0.8 0.7 Length of Life (Years) 10 5 7 7

Answer rating: 100% (QA)

Drugs QOL weight Tumorkinumab 0... View the full answer